Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - RESEARCH & DEVELOPMENT
Research & Development RARE - Ultragenyx Pharmaceutical Inc.
648 M
LAST VALUE
14.21%
2 YEAR CAGR
17.14%
5 YEAR CAGR
37.01%
10 YEAR CAGR